ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)
London-based Basecamp Research has raised a $140m Series C round led by California VC firm S32 to build next-generation biological foundation models and bring medicines designed through them to the clinic. The round included Anthropic, Nvidia, and other investors. The company plans to use the funding to advance its AI-driven drug discovery platform.
Tap to vote and see what everyone thinks.
Summary by ByteBrief